Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | IGF1R | P08069 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27177813 | 0.98 | TRPA1 (0.61) | TRPA1TRPV1MAOAFAAHTDP1 | |
| SCHEMBL27370822 | 0.98 | TRPA1 (0.61) | TRPA1TRPV1MAOAFAAHTDP1 | |
| SCHEMBL11549188 | 0.94 | TRPA1 (0.51) | TRPA1TRPV1MAOATDP1MAPT | |
| SCHEMBL19682101 | 0.88 | TRPA1 (0.67) | TRPA1TRPV1MAOAFAAHMAPT | |
| SCHEMBL2077325 | 0.85 | TDP1 (0.52) | TDP1SLC6A3 | |
| SCHEMBL2074517 | 0.85 | TDP1 (0.52) | TDP1SLC6A3 | |
| SCHEMBL2074824 | 0.85 | TDP1 (0.52) | TDP1SLC6A3 | |
| SCHEMBL7166933 | 0.84 | TRPA1 (0.58) | TRPA1TRPV1MAOAMAPTRXFP1 | |
| SCHEMBL3115450 | 0.84 | TRPA1 (0.58) | TRPA1TRPV1MAOAFAAHMAPT | |
| SCHEMBL5833581 | 0.83 | TRPA1 (0.56) | TRPA1TRPV1MAOATDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4354488-A1 | CURABLE COMPOSITION, FILM FORMATION METHOD, AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2024-04-17 | — | — | EP | disclosed |
| US-20240101842-A1 | CURABLE COMPOSITION, FILM FORMING METHOD AND ARTICLE MANUFACTURING METHOD | CANON KABUSHIKI KAISHA (JP) | 2024-03-28 | — | — | US | disclosed |
| WO-2023243484-A1 | CURABLE COMPOSITION, METHOD FOR FORMING INVERTED PATTERN, METHOD FOR FORMING FILM, AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-12-21 | — | — | WO | disclosed |
| WO-2023162519-A1 | PATTERN FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-08-31 | — | — | WO | disclosed |
| WO-2023153123-A1 | FILM FORMATION METHOD AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2023-08-17 | — | — | WO | disclosed |
| WO-2023112512-A1 | FILM FORMING METHOD AND METHOD FOR PRODUCING ARTICLE | キヤノン株式会社 | 2023-06-22 | — | — | WO | disclosed |
| WO-2022259748-A1 | CURABLE COMPOSITION, FILM FORMATION METHOD, AND ARTICLE MANUFACTURING METHOD | キヤノン株式会社 | 2022-12-15 | — | — | WO | disclosed |
| EP-3604373-A1 | STRETCHABLE FILM AND METHOD FOR FORMING THE SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2020-02-05 | — | — | EP | disclosed |
| CN-109863179-A | Free-radical polymerised resin combination | 昭和电工株式会社 | 2019-06-07 | — | — | CN | disclosed |
| CN-109071777-A | Carbon fiber-reinforced resin composition, carbon fiber-reinforced resin composition, solidfied material | 昭和电工株式会社 | 2018-12-21 | — | — | CN | disclosed |
| US-8829229-B2 | Polyol ethers and process for making them | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-09-09 | — | — | US | disclosed |
| EP-2318346-B1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-11-20 | — | — | EP | disclosed |
| EP-2426099-A1 | Coalescent for aqueous compositions | Rohm and Haas Company (US) | 2012-03-07 | — | — | EP | disclosed |
| US-20120052210-A1 | COALESCENT FOR AQUEOUS COMPOSITIONS | VAN DYK ANTONY KEITH (US) | 2012-03-01 | — | — | US | disclosed |
| CN-102131757-A | Polyol ethers and process for making them | DOW GLOBAL TECHNOLOGIES INC | 2011-07-20 | — | — | CN | disclosed |
| EP-2318346-A1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | Dow Global Technologies LLC (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010027663-A1 | POLYOL ETHERS AND PROCESS FOR MAKING THEM | DOW GLOBAL TECHNOLOGIES INC. (US) | 2010-03-11 | — | — | WO | disclosed |
| US-20100048940-A1 | reductive etherification of a polyol with an aldehyde or ketone using a hydrogenation catalyt; resulting compounds have use as solvents, surfactants, degreasers, wetting agents, emulsifying agents, lubricants, and intermediates for surfactants; polyols can be from renewable raw materials | DOW GLOBAL TECHNOLOGIES LLC | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048940-A1 | reductive etherification of a polyol with an aldehyde or ketone using a hydrogenation catalyt; resulting compounds have use as solvents, surfactants, degreasers, wetting agents, emulsifying agents, lubricants, and intermediates for surfactants; polyols can be from renewable raw materials | RNF114, USP14, USP13 | TRPA1 1549/4885TRPV1 3006/4885MAOA 3447/4885 |
| US-20120052210-A1 | COALESCENT FOR AQUEOUS COMPOSITIONS | DGAT2, DGAT1, DAGLB | TRPA1 2870/4885TRPV1 3213/4885MAOA 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.